|
Complement Blockade with a C1 Esterase Inhibitor in Paroxysmal Nocturnal Hemoglobinuria
|
Jul 2014
|
Exp Hematol
|
paroxysmal nocturnal hemoglobinuria (PNH)
|
|
Complement C3dg-mediated erythrophagocytosis: implications for paroxysmal nocturnal hemoglobinuria
|
Jun 2015
|
Blood
|
paroxysmal nocturnal hemoglobinuria (PNH)
|
|
Complement in paroxysmal nocturnal hemoglobinuria: exploiting our current knowledge to improve the treatment landscape
|
Sep 2014
|
Expert Rev Hematol
|
paroxysmal nocturnal hemoglobinuria (PNH)
|
|
Complement inhibition in medicine: Hematology and beyond; complement inhibition in hematology: PNH and beyond
|
May 2023
|
American Journal of Hematology
|
paroxysmal nocturnal hemoglobinuria (PNH)
|
|
Complement Inhibition in Paroxysmal Nocturnal Hemoglobinuria (PNH): A Systematic Review and Expert Opinion from Central Europe on Special Patient Populations
|
Jun 2023
|
Advances in Therapy
|
paroxysmal nocturnal hemoglobinuria (PNH)
|
|
Complement-driven anemia: more than just paroxysmal nocturnal hemoglobinuria.
|
Nov 2018
|
Hematology Am Soc Hematol Educ Program
|
paroxysmal nocturnal hemoglobinuria (PNH)
|
|
Computational Modeling and Treatment Identification in the Myelodysplastic Syndromes
|
Sep 2017
|
Curr Hematol Malig Rep
|
myelodysplastic syndromes (MDS)
|
|
Concurrent treatment of aplastic anemia/Paroxysmal Nocturnal Hemoglobinuria syndrome with immunosuppressive therapy and eculizumab: a UK experience
|
Mar 2018
|
Haematologica
|
aplastic anemia, paroxysmal nocturnal hemoglobinuria (PNH)
|
|
Conditional survival and standardized mortality ratios of patients with severe aplastic anemia surviving at least one year after hematopoietic cell transplantation or immunosuppressive therapy
|
Jun 2023
|
Haematologica
|
aplastic anemia
|
|
Connect MDS/AML: design of the myelodysplastic syndromes and acute myeloid leukemia disease registry, a prospective observational cohort study.
|
Aug 2016
|
BMC Cancer
|
myelodysplastic syndromes (MDS)
|
